Blueprint Medicines Corp (BPMC) Insider Trading & SEC Filings

Updated Jul 16, 2026 · Last SEC filing 2025-07-17

Blueprint Medicines Corp (BPMC) — no SEC Form 4 insider filings recorded in the last 90 days. InsiderAlpha tracks every BPMC SEC filing — Form 4, Form 144, and 8-K — in real time, including Rule 10b5-1 plan detection.

About Blueprint Medicines Corp (BPMC)

SEC CIK	0001597264

Recent BPMC Insider Transactions (Form 4)

Date	Insider	Role	Transaction	Shares	Price	Value	Filing
2025-07-17	Borisy Alexis	Director	J — Other acquisition / disposition	74.2K	—	—	SEC
2025-07-17	Seely Lynn	Director	D — Derivative transaction	3.9K	—	—	SEC
2025-07-17	Seely Lynn	Director	J — Other acquisition / disposition	13.3K	—	—	SEC
2025-07-17	Beckman Daniella	Director	D — Derivative transaction	3.9K	—	—	SEC
2025-07-17	Beckman Daniella	Director	J — Other acquisition / disposition	10.8K	—	—	SEC
2025-07-17	Goldberg Mark Alan	Director	D — Derivative transaction	3.9K	—	—	SEC
2025-07-17	Goldberg Mark Alan	Director	J — Other acquisition / disposition	18.3K	—	—	SEC
2025-07-17	Lee Philina	Chief Commercial Officer	A — Grant or award	21.4K	—	—	SEC
2025-07-17	Lee Philina	Chief Commercial Officer	D — Derivative transaction	50.2K	—	—	SEC
2025-07-17	Lee Philina	Chief Commercial Officer	J — Other acquisition / disposition	13.2K	—	—	SEC
2025-07-17	Tsai John	Director	D — Derivative transaction	3.9K	—	—	SEC
2025-07-17	Tsai John	Director	J — Other acquisition / disposition	8.7K	—	—	SEC
2025-07-17	Namouni Fouad	PRESIDENT, R D	A — Grant or award	39.5K	—	—	SEC
2025-07-17	Namouni Fouad	PRESIDENT, R D	D — Derivative transaction	83.3K	—	—	SEC
2025-07-17	Borisy Alexis	Director	D — Derivative transaction	3.9K	—	—	SEC

All transactions sourced from SEC EDGAR Form 4 filings for Blueprint Medicines Corp (BPMC). Updated in real time as new filings are submitted to the SEC.

Recent Insider Filings

2025-07-17 — Seely Lynn (Director)
2025-07-17 — Beckman Daniella (Director)
2025-07-17 — Goldberg Mark Alan (Director)
2025-07-17 — Lee Philina (Chief Commercial Officer)
2025-07-17 — Borisy Alexis (Director)

Form 4 Transaction Code Reference

SEC Form 4 transactions are reported with a one-letter code indicating the type of transaction. Common codes you'll see in BPMC insider filings:

P	Open-market purchase by the insider
S	Open-market sale by the insider
A	Grant, award, or other acquisition from the issuer
M	Exercise or conversion of derivative security (e.g. options)
F	Payment of exercise price or tax liability via share withholding
G	Bona-fide gift of securities
D	Disposition to the issuer (e.g. share buyback participation)
J	Other acquisition or disposition
X	Exercise of in-the-money or at-the-money derivative security
C	Conversion of derivative security
V	Transaction voluntarily reported earlier than required

BPMC Insider Trading — FAQ

What is the latest insider trade for BPMC?: Blueprint Medicines Corp (BPMC) had 0 insider filings in the last 90 days, with the most recent on 2025-07-17. InsiderAlpha tracks every Form 4, 10-K, 10-Q, and 8-K filing in real time.
How many insiders are buying BPMC stock?: 0 insider purchases of BPMC were filed in the last 90 days.
How many insiders are selling BPMC stock?: 0 insider sales of BPMC were filed in the last 90 days.
Where can I see BPMC SEC filings (Form 4, 10-K, 10-Q, 8-K)?: InsiderAlpha aggregates every BPMC SEC filing — Form 4 insider transactions, 10-K and 10-Q quarterly reports, and 8-K material event disclosures — in one timeline.

Learn More

Open the live BPMC dashboard on InsiderAlpha for real-time alerts, charting, and full historical filing search.